Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MGAM | O43451 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | SI | P14410 | 1/20 | 0.30 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.30 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16658461 | 0.83 | CYP4F2 (0.39) | ALDH1A1SMN1; SMN2LMNAMMP8PKM | |
| SCHEMBL16663581 | 0.78 | ALDH1A1 (0.33) | ALDH1A1LMNAGAA | |
| SCHEMBL16658459 | 0.78 | TSHR (0.32) | ALDH1A1LMNA | |
| SCHEMBL7560874 | 0.76 | KMT2A (0.35) | DGAT1ALDH1A1HTTSMN1; SMN2LMNA | |
| SCHEMBL445544 | 0.73 | DGAT1 (0.39) | DGAT1ALDH1A1HTTSMN1; SMN2CA2 | |
| SCHEMBL17358987 | 0.73 | DGAT1 (0.39) | DGAT1ALDH1A1HTTCA1CA2 | |
| SCHEMBL11659311 | 0.72 | LMNA (0.36) | DGAT1ALDH1A1HTTSMN1; SMN2LMNA | |
| SCHEMBL12761004 | 0.72 | DGAT1 (0.42) | DGAT1ALDH1A1SMN1; SMN2LMNAGAA | |
| SCHEMBL15951338 | 0.70 | MGAM (0.36) | DGAT1ALDH1A1HTTLMNAMGAM | |
| SCHEMBL27972010 | 0.70 | DGAT1 (0.37) | DGAT1ALDH1A1MGAMGAASI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150112036-A1 | PARTIALLY FLUORINATED POLYMERS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-04-23 | — | — | US | disclosed |
| US-20150112095-A1 | PARTIALLY FLUORINATED ALCOHOLS AND DERIVATIVES | E I DU PONT DE NEMOURS AND COMPANY (DE) | 2015-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150112095-A1 | PARTIALLY FLUORINATED ALCOHOLS AND DERIVATIVES | ADH1C, ADH1A, AFF1 | DGAT1 580/4885ALDH1A1 126/4885HTT 3432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.